QTRX Stock Analysis: Buy, Sell, or Hold?
QTRX - Quanterix Corporation Common Stock
$6.34
-0.35 (-5.23%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When QTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: QTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: QTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: QTRX is currently trading at $6.34, which is considered fair relative to its 30-day fair value range of $6.38 to $7.33.
Technical Outlook: Technically, QTRX is in a strong uptrend. The price is currently testing key support at $6.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QTRX is in a strong uptrend. The price is currently testing key support at $6.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.38 -
$7.33
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- NEUTRAL: Near Wall St target ($7.33)
Fair Price Analysis
30-Day Fair Range
$6.38 -
$7.33
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$6.33
Resistance Level
$8.15
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.76
Wall Street Target
$7.33
(+9.6%)
Revenue Growth (YoY)
12.3%
Profit Margin
-73.5%
Last updated: January 31, 2026 10:05 AM ET
Data refreshes hourly during market hours. Next update: 11:05 AM
Data refreshes hourly during market hours. Next update: 11:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced QTRX Option Strategies
Professional options setups generated by AI based on today's QTRX price and gamma walls.
